Evidence map›Paper›PMID 41513942›Full record

ArticleScientific reports2026

Association of cardiovascular risk factors with diabetic kidney disease severity in the Iranian population.

Rad Ghannadzadeh Kermani Pour, Maryam Karimi Ghahfarokhi, Ali Golestani, Shahrzad Mohseni, Sepehr Khosravi, Alireza Azarboo, Mohammadreza Mohajeri-Tehrani, Mahnaz Pejman Sani, Ozra Tabatabaei-Malazy

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Rad Ghannadzadeh Kermani PourNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Maryam Karimi GhahfarokhiNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Ali GolestaniNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Shahrzad MohseniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sepehr KhosraviNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Alireza AzarbooEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mohammadreza Mohajeri-TehraniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mahnaz Pejman SaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. mpsani@sina.tums.ac.ir.
Ozra Tabatabaei-MalazyNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. tabatabaeiml@sina.tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic Kidney Disease (DKD), a serious complication of diabetes mellitus, is a leading cause of end-stage renal disease and a significantly contributes to cardiovascular morbidity. This study investigated the association of cardiovascular disease (CVD) risk factors with the severity of DKD in the Iranian population. Utilizing data from the 2021 nationwide STEPwise approach to Noncommunicable Disease Risk Factor Surveillance, this cross-sectional analysis included 3272 diabetic adults aged ≥ 25 years. DKD was defined based on estimated glomerular filtration rate (eGFR) and albuminuria levels using the KDIGO guideline. Key CVD risk factors were examined through multivariable ordinal logistic regression analysis. Among the participants, 7.64% (95% CI 6.73,8.55) and 20.3% (95% CI 18.92,21.68) were classified as having high/very high and moderately DKD risk, respectively. Older age [adjusted odds ratio (AOR) = 1.81, 95% CI 1.19,2.73], longer diabetes duration (≥ 10 years) (AOR = 1.33, 95% CI 1.07,1.64), ever smoking (AOR = 1.31, 95% CI 1.07,1.60), systolic blood pressure (SBP) ≥ 140 mmHg (AOR = 1.42, 95% CI 1.17,1.73), uncontrolled glycemic status (HbA1c ≥ 7) (AOR = 1.57, 95% CI: 1.32,1.88), dyslipidemia (AOR = 1.53, 955 CI 1.12,2.07), use of insulin (AOR = 2.45, 95% CI 1.59,3.75) and multiple antihypertensive medications (AOR = 2.15, 95% CI 1.63,2.85) were significantly associated with higher DKD severity. Conversely, higher education (≥ 12 years) (AOR: 0.74, 95% CI 0.59,0.92, p = 0.007) was associated with lower DKD severity. CVD risk factors, particularly hypertension, dyslipidemia, and poor glycemic control, exhibited strong associations with the severity of DKD. These findings underscore the importance of early risk stratification and the implementation of targeted interventions to delay renal deterioration among patients with diabetes.

Indexed as

Cardiovascular DiseasesDiabetic NephropathiesAdultAgedBlood PressureCross-Sectional StudiesFemaleGlomerular Filtration RateHeart Disease Risk FactorsHumansIranMaleMiddle AgedRisk FactorsSeverity of Illness IndexCardiovascular risk factorsDiabetes mellitusDiabetic kidney diseaseDyslipidemiaGlycemic controlHypertension

Identifiers

PMID41513942
PMCPMC12868775

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.